Developing an Artificial Intelligence System to Detect Cognitive Impairment
1 other identifier
observational
3,413
1 country
1
Brief Summary
Alzheimer's disease dementia (AD) is a debilitating and prevalent neurodegenerative disease in older adults globally. Cognitive impairment, a hallmark of AD, is assessed through verbal tests that require high specialization, and while accepted as screening tools for AD, general practitioners seldom use them. AD can be diagnosed with expensive, invasive neuroimaging and blood tests, but these are usually conducted when cognitive functioning is already severely impaired. Thus, finding a novel, non-invasive tool to detect and differentiate mild cognitive impairment (MCI) and AD is a prime public health interest. Self-figure drawings (a projective tool in which individuals are asked to draw a picture of themselves), are easy to administer and have been shown to differentiate between healthy and cognitively impaired individuals, including AD. Convolutional Neural Network (CNN) (a type of deep neural network, applied to analyze visual imagery) has advanced to assess health conditions using art products. Therefore, the proposed study suggests utilizing CNN-based methods to develop and test an application tailored to differentiate between drawings of individuals with MCI, AD, and healthy controls (HC) using 4,000 self-figure drawings. This
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 20, 2023
CompletedStudy Start
First participant enrolled
March 20, 2023
CompletedFirst Posted
Study publicly available on registry
April 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2026
CompletedMay 4, 2026
April 1, 2026
2.8 years
March 20, 2023
April 28, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Cognition
The Montreal Cognitive Assessment (MoCA) is a 10-minute paper-based test that aims to detect MCI in older patients with symptomatology, suggesting impaired cognition. The MoCA is composed of 12 tasks to detect short-term memory, visuospatial ability, executive functioning, phonemic fluency, abstraction, attention, concentration, working memory, language, and orientation.
One day
Cognition for adults diagnosed with Alzheimer's disease
The Self-reported Cognitive Difficulties (CDS)75 is a 39-item questionnaire that requires participants or their caregivers in case of AD to rate how often they currently experience cognitive difficulties in everyday life using a 5-point scale (0 -"never" to 4 -"very often").
One day
Self-figure drawing -Cognition
Self-figure drawing. Participants will be asked to draw themselves using a pencil on an A4-sized sheet of paper.
One day
Study Arms (3)
Healthy controls
Adults aged 60 and above without cognitive impairment
Mild cognitive impairment
Adults 60 and above with mild cognitive impairment
Alzheimer's disease
Adults diagnosed with Alzheimer's disease
Eligibility Criteria
Adults aged 60 or above, who live in Israel.
You may qualify if:
- Adults aged 60 and above with subtle signs of risk of future cognitive decline, residing in the community or in nursing homes with a minimum of 10 years of education.
You may not qualify if:
- Current or past psychiatric illness, the presence of congenital/organic cognitive condition, severe visual or motor impairment, and terminal illness (to avoid the effect of comorbidities).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Haifalead
- Technion, Israel Institute of Technologycollaborator
Study Sites (1)
University of Haifa
Haifa, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Johanna Czamanski-Cohen, PhD
University of Haifa
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Lecturer
Study Record Dates
First Submitted
March 20, 2023
First Posted
April 3, 2023
Study Start
March 20, 2023
Primary Completion
December 31, 2025
Study Completion
March 31, 2026
Last Updated
May 4, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
This is an artificial intelligence study, thus there will not be a dataset available for sharing.